| Literature DB >> 17994219 |
Abstract
Entities:
Mesh:
Year: 2007 PMID: 17994219 PMCID: PMC2798993 DOI: 10.1007/s00134-007-0932-4
Source DB: PubMed Journal: Intensive Care Med ISSN: 0342-4642 Impact factor: 17.440
| Monday 22 September 2008 | |
| Oral Presentations | |
| Sepsis: Basic studies | 0001–0005 |
| Pathophysiological approach of cardiovascular failure | 0006–0010 |
| Surviving the ICU: Clinician's perspectives | 0011–0014 |
| ICU management | 0015–0018 |
| New aspects of mechanical ventilation in acute lung injury | 0019–0023 |
| New dimensions in nursing | 0024–0028 |
| Poster Sessions | |
| Various | 0029–0042 |
| Perioperative monitoring and outcome | 0043–0053 |
| Severity scoring | 0054–0067 |
| Technology assessment monitoring I | 0068–0080 |
| Pathophysiology of sepsis I | 0081–0094 |
| Antibiotics in the ICU | 0095–0108 |
| Sepsis: Predisposition and outcome | 0109–0122 |
| Ventilator-associated pneumonia | 0123–0136 |
| Advances in critical care I | 0137–0150 |
| Quality improvement | 0151–0164 |
| Circulatory issues and prognosis | 0165–0177 |
| Signaling pathways in acute lung injury | 0178–0191 |
| Sepsis: Cardiovascular therapies | 0192–0205 |
| Organ donation | 0206–0215 |
| Pathophysiology of sepsis II | 0216–0229 |
| Mechanical ventilation: Patient-ventilator interaction | 0230–0243 |
| Assessment of fluid resuscitation | 0244–0253 |
| Advances in neuro-critical care I | 0254–0267 |
| Resource management | 0268–0281 |
| Technology assessment monitoring II | 0282–0294 |
| Weaning from mechanical ventilation | 0295–0308 |
| Advances in neuro-critical care II | 0309–0322 |
| Perioperative cardiac problems | 0323–0333 |
| Non-invasive ventilation in the ICU | 0334–0344 |
| Oral Presentations | |
| Sepsis: Clinical studies | 0345–0350 |
| Advances in neuro-critical care III | 0351–0356 |
| ICU admission | 0357–0362 |
| Molecular mechanisms of acute lung injury | 0363–0368 |
| Metabolism endocrinology | 0369–0374 |
| Septic shock | 0375–0380 |
| Cultural variations at the end-of-life | 0381–0386 |
| Tuesday 23 September 2008 | |
| Oral Presentations | |
| Abstract awards winners — The best preselected abstracts submitted to the congress | 0387–0390 |
| Microcirculation in sepsis | 0391–0395 |
| Perioperative organ failure | 0396–0400 |
| Paediatric intensive care | 0401–0405 |
| Lung imaging and monitoring | 0406–0410 |
| Ventilator-associated pneumonia: Can we prevent? | 0411–0414 |
| Poster Sessions | |
| Sedation, analgesia, pharmacology | 0415–0428 |
| Fungal infections/Device-related infections | 0429–0442 |
| Advances in neuro-critical care IV | 0443–0456 |
| Sepsis: Experimental | 0457–0470 |
| Perioperative infections | 0471–0477 |
| Tracheostomy in the ICU | 0478–0488 |
| Infection and sepsis | 0489–0498 |
| Creative nursing | 0499–0511 |
| Alternative strategies for oxygenation and CO2-removal | 0512–0523 |
| Prognosis and outcome | 0524–0537 |
| Technology assessment organ support I | 0538–0551 |
| Pediatric and neonatal care | 0552–0563 |
| Clinical outcome I | 0564–0577 |
| Microcirculation in the critically ill | 0578–0591 |
| Sepsis therapies | 0592–0605 |
| Physiotherapy and patient's outcome | 0606–0614 |
| Determination of cardiac function | 0615–0627 |
| Recruitment maneuvers in ALI and ARDS | 0628–0641 |
| Clinical outcome II | 0642–0654 |
| ALI in the ICU: Diagnosis, treatment, outcome | 0655–0664 |
| Advances in neuro-critical care V | 0665–0678 |
| Perioperative hormones and metabolic problems | 0679–0690 |
| Advances in critical care II | 0691–0704 |
| Multi-resistant infections | 0705–0718 |
| Oral Presentations | |
| Sepsis: Experimental studies | 0719–0724 |
| Functional approach of cardiovascular failure | 0725–0730 |
| Advances in neuro-critical care VI | 0731–0735 |
| Perioperative monitoring | 0736–0741 |
| Long term outcome | 0742–0747 |
| Ventilator-associated pneumonia: Treatment | 0748–0753 |
| Technology assessment organ support II | 0754–0759 |
| Wednesday 24 September 2008 | |
| Oral Presentations | |
| Acute kidney injury | 0760–0764 |
| Biomarkers in sepsis | 0765–0769 |
| Advances in neuro-critical care VII | 0770–0772 |
| Implementing quality indicators | 0773–0777 |
| Technology assessment monitoring III | 0778–0782 |
| Physiotherapy: Respiration and locomotion | 0783–0786 |
| Poster Sessions | |
| SIRS, MODS and shock | 0787–0800 |
| Perioperative pain and abdominal problems | 0801–0814 |
| Sepsis and SIRS: Varias | 0815–0823 |
| Advances in critical care III | 0824–0837 |
| Improving ICU | 0838–0842 |
| Advances in neuro-critical care VIII | 0843–0856 |
| Glucose control | 0857–0870 |
| Microcirulation and coagulation | 0871–0883 |
| Nutrition | 0884–0897 |
| Severe infections I | 0898–0911 |
| Endocrinology — Nutrition | 0912–0925 |
| Surviving sepsis | 0926–0939 |
| Acid base — Renal replacement therapy | 0940–0953 |
| Respiratory failure: Therapeutic strategies and measures | 0954–0966 |
| Acute kidney injury | 0967–0980 |
| Management of cardiac failure | 0981–0990 |
| Severe infections II | 0991–1001 |
| Microcirculation and prognosis | 1002–1015 |
| Perioperative lung injury | 1016–1029 |
| Severe infections III | 1030–1043 |
| Practices at the end of life | 1044–1052 |